Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes.
Chronic KRT
Heart failure
Hemodialysis
Kidney failure
LVAD
Journal
Advances in chronic kidney disease
ISSN: 1548-5609
Titre abrégé: Adv Chronic Kidney Dis
Pays: United States
ID NLM: 101209214
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
31
07
2020
revised:
12
11
2020
accepted:
04
01
2021
entrez:
14
8
2021
pubmed:
15
8
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
Heart failure and kidney failure are very common conditions, precipitating and exacerbating each other. Left ventricular assist devices (LVADs) represent a relatively new technology for treatment of advanced heart failure. Kidney dysfunction, if present, makes candidate selection for LVADs challenging and contributes to multiple complications while the patients are on an LVAD support. Although kidney function generally improves after LVAD implantation, some patients develop acute and then chronic kidney disease sometimes requiring kidney replacement therapies (KRTs). Overall, chronic KRT in LVAD recipients is feasible and well tolerated, but routine technique of blood pressure monitoring should be adjusted to the continuous blood flow. Both hemodialysis and peritoneal dialysis can be used. Unique challenges for chronic KRT posed by the presence of LVAD are discussed in this review.
Identifiants
pubmed: 34389136
pii: S1548-5595(21)00002-1
doi: 10.1053/j.ackd.2021.01.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
37-46Informations de copyright
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.